Interventional cardiac catheterization advances in nonsurgical approaches to congenital heart disease

Current Opinion in Pediatrics

Volumn 11, Issue 5, 1999, Pages 425-432

  Cowley, Collin G ^a   Lloyd, Thomas R ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MCHC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA COARCTATION; CHILD; CONGENITAL HEART DISEASE; CORONARY STENT; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HUMAN; PATENT DUCTUS ARTERIOSUS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PULMONARY VALVE; REVIEW; TRANSLUMINAL VALVULOPLASTY;

EID: 0032851928     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199910000-00009     Document Type: Review

References (96)

1. Shim D, Lloyd T, Crowley D, Beekman R: Neonatal cardiac catheterization: a 10-year transition from diagnosis to therapy. Pediatr Cardiol 1999, 20:131-133.
2. Masura J, Gavora P, Formanek A, Hijazi Z: Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997, 42:388-393.
3. Thanopoulos B, Laskari C, Tsaousis G, Zarayelyan A, Vekiou A, Papadopoulis G: Closure of atrial septal defects with the Amplatzer occlusion device: preliminary results. J Am Coll Cardiol 1998, 31:1110-1116.
4. Hijazi Z, Cao Q, Patel H, Rhodes J: Transcatheter closure of atrial communications using the Amplatzer septal occluder. J Intervent Cardiol 1999, 12:51-58.
5. Hakim F, Madani A, Samara Y, Ata I, Hiari A, Goussous Y, Hijazi Z: Transcatheter closure of secundum atrial defect in a patient with dextrocardia using the Amplatzer septal occluder. Cathet Cardiovasc Diagn 1998, 4:291-294.
6. Pedra C, Fontes-Pedra S, Esteves C, Assef J, Fontes V, Hijazi Z: Multiple atrial septal defects and patent ductus arteriosus: successful outcome using two Amplatzer septal occluders and Gianturco coils. Cathet Cardiovasc Diagn 1997, 42:257-259.
7. Tofeig M, Walsh K, Chan C, Ladusans E, Gladman G, Arnold R: Occlusion of Fontan fenestrations using the Amplatzer septal occluder. Heart 1998, 79:368-370.
8. Sievert H, Babic U, Hausdorf G, Scneider M, Hopp H, Pfeiffer D, et al.: Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol 1998, 82:1405-1413. The authors report placement of 174 ASDOS (ASDOS, Sulzer Osypka, Reinfelden, Germany) devices in 200 patients. At 6 months, 24 patients had small residual shunts and five had moderate to large residual shunts. Twenty devices were retrieved percutaneously and six additional devices were surgically removed.
9. Babic U: The ASDOS device: technique and guidelines for clinical use. J Intervent Cardiol 1998, 11(5 part 1):485-494.
10. Hausdorf G, Schneider M, Fink C, Neudorf U, Fischer G, Tynan M, Friedli B: Transcatheter closure of atrial septal defects within the oval fossa: medium-term results in children using the ASDOS-technique. Cardiol Young 1998, 8:462-471.
11. Rickers C, Hamm C, Stern H, Hofmann T, Franzen O, Schrader R, et al.: Percutaneous closure of secundum atrial septal defect with a new self centering device ("Angel Wings"). Heart 1998, 80:517-521.
12. Mendelsohn A, Banerjee A, Schwartz D, Das G: Transcatheter atrial septal defect closure with the Das Angel Wings transcatheter ASD occlusion device: the Cincinnati-Rochester experience. J Intervent Cardiol 1998, 11:495-500.
13. Zamora R, Rao P, Lloyd T, Beekman R, Sideris E: Intermediate term results of phase I Food and Drug Administration trials of Buttoned device occlusion of secundum atrial septal defects. J Am Coll Cardiol 1998, 31:674-676.
14. Rao P, Sideris E: Buttoned device closure of the atrial septal defect. J Intervent Cardiol 1998, 11:467-484.
15. Latson L: The CardioSEAL device: history, techniques, results. J Intervent Cardiol 1998, 11:501-505.
16. Kaulitz R, Paul T, Hausdorf G: Extending the limits of transcatheter closure of atrial septal defects with the double umbrella device (CardioSEAL [Nitinol Med Tech Inc., Boston, MA, USA]). Heart 1998, 80:54-59.
17. Formigari R, Santoro G, Rossetti L, Rinelli G, Guccione P, Ballerini L: Comparison of three different atrial septal defect occlusion devices. Am J Cardiol 1998, 82:690-692.
18. Gu X, Han Y, Berry J, Urness M, Amplatz K: A new technique for sizing of atrial septal defects. Cathet Cardiovasc Diagn 1999, 46:51-57.
19. Schrader R, Hofstetter R, Fabbender D, Berger F, Bubmann W, Ernst J, et al.: Transvenous closure of patent ductus arteriosus with Ivalon plugs: multicenter experience with a new technology. Invest Radiol 1999, 34:65-70. Ninety-eight of 100 patients had successfully placed Ivalon plugs for patent ductus arteriosus. A high rate of retrieval for malposition and a high incidence of residual shunting occurred.
20. Wang L-H, Wang J-K, Mullins C: Eradicating acute hemolysis following transcatheter closure of ductus arteriosus by immediate deployment of a second device. Cathet Cardiovasc Diagn 1998, 43:295-297.
21. Moore J, Shim D, Mendelsohn A, Kimball T: Coarctation of the aorta following coil occlusion of a patent ductus arteriosus. Cathet Cardiovasc Diagn 1998, 43:60-62.
22. Ing F, Mullins C, Wolfe S, Grifka R: Relief of factitious coarctation of the aorta following occlusion of large patent ductus arteriosus with Gianturco-Grifka vascular occluder. Cathet Cardiovasc Diagn 1998, 45:409-412.
23. Rao P, Kim S, Choi J-Y, Rey C, Haddad J, Marcon F, et al.: Follow-up results of transvenous occlusion of patent ductus arteriosus with the Buttoned Device. J Am Coll Cardiol 1999, 33:820-826.
24. Masura J, Walsh K, Thanapolous B, Chan C, Bass J, Goussous Y, et al.: Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer Duct Occluder: immediate and short term results. J Am Coll Cardiol 1998, 31:878-882. These researchers accomplished successful closure in 24 of 24 patients with no residual shunt and no complications.
25. Gray D, Weinstein M: Decision and cost-utility analyses of surgical versus transcatheter closure of patent ductus arteriosus: should you let a smile be your umbrella. Med Decis Making 1998, 18:187-201.
26. Ino T, Kishiro M, Yamashiro Y, Tanaka A, Ito H: Experimental study of coil embolization using a new atellocollagan spring coil. Pediatr Res 1998, 43:532-535. Using animal studies, the authors demonstrate excellent preliminary results in the use of this biodegradable coil.
27. Lloyd T, Beekman R: Clinically silent patent ductus arteriosus. Am Heart J 1994, 127:1664.
28. Balzer D, Spray T, McMullin D, Cottingham W, Canter C: Endarteritis associated with a clinically silent patent ductus arteriosus. Am Heart J 1993, 125:1182-1193.
29. Latson L: Residual shunts after transcatheter closure of patent ductus arteriosus: a major concern or benign "techno-malady"? Circulation 1991, 84:2591-2593.
30. Shim D, Wechsler D, Lloyd T, Beekman R: Hemolysis following coil embolization of patent ductus arteriosus. Cathet Cardiovasc Diagn 1996, 39:287-290.
31. Henry G, Danilowicz D, Verma R: Severe hemolysis following partial coil occlusion of a patent ductus arteriosus. Cathet Cardiovasc Diagn 1996, 39:410-412.
32. Johnston T, Stern H, O'Laughlin M: Transcatheter occlusion of the patent ductus arteriosus: use of retrievable coils. Cathet Cardiovasc Intervent 1999, 46:434-437.
33. Bermudez-Canete R, Santoro G, Bialkowsky J, Herraiz I, Formigari R, Szkutnik M, Ballerini L: Patent ductus arteriosus occlusion using detachable coils. Am J Cardiol 1998, 82:1547-1549. In this large series, 181 of 193 patients underwent successful coil embolization, with 11 patients demonstrating a residual shunt at last follow-up. All complications were effectively treated with no significant sequelae.
34. Goyal V, Fulwani M, Ramakantan R, Kulkarni H, Dalvi B: Follow-up after coil closure of patent ductus arteriosus. Am J Cardiol 1999, 83:463-466.
35. Weber H, Cyran S: Transvenous "snare-assisted" coil occlusion of patent ductus arteriosus. Am J Cardiol 1998, 82:248-251.
36. Dalvi B, Nabar A, Goyal V, Naik A, Kulkarni H, Ramakanthan R: Transcatheter closure of patent ductus arteriosus in children weighing < 10 kg with Gianturco coils using the balloon occlusion technique. Cathet Cardiovasc Diagn 1998, 44:303-308.
37. Moore J, Boosfeld C: The Duct-Occlud device for closure of patent ductus arteriosus. J Intervent Cardiol 1999, 12:65-71.
38. Berman W, Raisher B, Fripp R, Yabek S: Vessel-sparing technique for coil occlusion of the very small patent ductus arteriosus. Cathet Cardiovasc Intervent 1999, 46:338-339.
39. Rao P, Kim S, Rey C, Onorato E, Sideris E: Results of transvenous Buttoned device occlusion of patent ductus arteriosus. Am J Cardiol 1998, 82:827-829. In this article, the authors report on results of this multi-institutional trial with a 14% 1-year actuarial residual shunt rate. Two devices were later surgically removed for hemolysis.
40. Daniels C, Cassidy S, Teske D, Wheller J, Allen H: Reopening after successful occlusion for patent ductus arteriosus. J Am Coll Cardiol 1998, 31:444-450.
41. Podnar T, Masura J: Transcatheter occlusion of residual patent ductus arteriosus after surgical ligation. Pediatr Cardiol 1999, 20:126-130.
42. Wong J, Shim D, Khoury P, Meyer R: Validation of color Doppler measurements of minimum patent ductus arteriosus diameters: significance for coil embolization. Am Heart J 1998, 136:714-717.
43. Prieto L, Decamillo D, Konrad D, Scaletlongworth L, Latson L: Comparison of cost and clinical outcome between transcatheter coil occlusion and surgical closure of the isolated patent ductus arteriosus. Pediatrics 1998, 101:1020-1024.
44. Heng JT, De Giovanni J: Occlusion of persistent left superior vena cava to unroofed coronary sinus using vena cava filter and coils. Heart 1997, 77:579-580.
45. Maheshwari S, Pollak J, Hellenbrand W: Transcatheter closure of an anomalous venous connection by a novel method. Cathet Cardiovasc Diagn 1998, 45:269-271.
46. Gamillscheg A, Beitzke A, Stein J, Rupitz M, Zobel G, Rigler B: Transcatheter coil occlusion of residual interatrial communications after Fontan procedure. Heart 1999, 80:49-53.
47. Hakim F, Madani A, Goussous Y, Cao Q-L, Hijazi Z: Transcatheter closure of a large coronary arteriovenous fistula using the new Amplatzer duct occluder. Cathet Cardiovasc Diagn 1998, 45:155-157.
48. Briceij V, Robida A: Coil occlusion of arteriovenous fistula of the vertebral artery in a child. Cathet Cardiovasc Diagn 1998, 43:434-437.
49. Clapp S, Morrow W: Development of superior vena cava to pulmonary vein fistulae following modified Fontan operation: case report of a rare anomaly and embolization therapy. Pediatr Cardiol 1998, 19:363-365.
50. Vance M: Use of platinum microcoils to embolize vascular abnormalities in children with congenital heart disease. Pediatr Cardiol 1998, 19:145-149.
51. Tulloh R, Rigby M: Transcatheter umbrella closure of aorto-pulmonary window. Heart 1997, 77:479-480.
52. Lane G, Lucas V, Sklansky M, Kashani I, Rothman A: Percutaneous coil occlusion of ascending aorta to pulmonary artery shunts. Am J Cardiol 1998, 81:1389-1391.
53. Janorkar S, Goh T, Wilkinson J: Tranacatheter closure of ventricular septal defects using the Rashkind device: initial experience. Cathet Cardiovasc Intervent 1999, 46:43-48. These researchers attempted transcatheter closure of 25 ventricular septal defects in 16 surgically high-risk patients. The researchers placed twenty-two devices successfully, with two patient deaths.
54. Shaffer K, Mullins C, Grifka R, O'Laughlin M, McMahon W, Ing F, Nihill M: Intravascular stents in congenital heart disease: short- and long-term results from a large single-center experience. J Am Coll Cardiol 1998, 31:661-667. In this article, the authors reported on a substantial single-center experience with 347 Palmaz stents in 200 patients with postoperative pulmonary artery stenosis, congenital pulmonary artery stenosis, or stenosis of systemic veins or venous anastomoses. Despite two deaths, the authors reported excellent immediate and long-term relief of obstruction and no late morbidity.
55. Schneider M, Zartner P, Sidiropolous A, Konertz W, Hausdorf G: Stent implantation of the arterial duct in newborns with duct-dependent circulation. Eur Heart J 1998, 19:1401-1409.
56. Zahn E, Chang A, Aldousany A, Burke R: Emergent stent placement for acute Blalock-Taussig shunt obstruction after stage 1 Norwood surgery. Cathet Cardiovasc Diagn 1997, 42:191-194.
57. Peuster M, Fink C, Bertram H, Paul T, Hausdorf G: Transcatheter recanalization and subsequent stent implantation for the treatment of early postoperative thrombosis of modified Blalock-Taussig shunts in two children. Cathet Cardiovasc Diagn 1998, 45:405-408.
58. Hashmi A, Lazzam C, McCrindle B, Benson L: Stenting of coronary artery stenosis in Kawasaki disease. Cathet Cardiovasc Diagn 1999, 46:333-336.
59. Moore J, Buchbinder M: Successful coronary artery Stenting in a 4-year-old child. Cathet Cardiovasc Diagn 1998,44:202-205.
60. Khanal S, Ribeiro P, Platt M, Kuhn M: Right coronary artery occlusion as a complication of accessory pathway ablation in a 12-year-old treated with Stenting. Cathet Cardiovasc Diagn 1999, 46:59-61.
61. Fletcher S, Cheatham J, Froeming S: Aortic aneurysm following primary balloon angioplasty and secondary endovascular stent placement in the treatment of native coarctation of the aorta. Cathet Cardiovasc Diagn 1998, 44:40-44.
62. de Lozo J, Pan M, Romero M, Medina A, Segura A, Lefuente M, et al.: Immediate and follow-up findings after stent treatment for severe coarctation of the aorta. Am J Cardiol 1999, 83:400-406.
63. Bu'Lock F, Tometzki A, Kitchener D, Arnold R, Peart I, Walsh K: Balloon expandable stents for systemic venous pathway stenosis late after Mustard's operation. Heart 1998, 79:225-229.
64. Brown S, Eyskens B, Mertens L, Stockx L, Dumoulin M, Gewillig M: Self expandable stents for relief of venous baffle obstruction after the Mustard operation. Heart 1998, 79:230-233.
65. Coulson J, Bullaboy C: Concentric placement of stents to relieve an obstructed anomalous pulmonary venous connection. Cathet Cardiovasc Diagn 1997, 42:201-204.
66. Vance M: Use of Palmez stents to palliate pulmonary atresia with ventricular septal defect and stenotic aortopulmonary collaterals. Cathet Cardiovasc Diagn 1997, 40:387-389.
67. Hijazi Z, Ruiz C, Patel H, Cao Q-L, Dorros G: Catheter therapy for Fontan baffle obstruction and leak, using an endovascular covered stent. Cathet Cardiovasc Diagn 1998, 45:158-161.
68. Magee A, Nykanen D, McCrindle B, Wax D, Freedom R, Benson L: Balloon dilation of severe aortic stenosis in the neonate: comparison of anterograde and retrograde catheter approaches. J Am Coll Cardiol 1997, 31:1061-1066.
69. Galal O, Rao S, Al-Fadley F, Wilson A: Follow-up results of balloon aortic valvuloplasty in children with special reference to causes of late aortic insufficiency. Am Heart J 1997, 133:418-427.
70. Goel P, Kapoor A, Singh R: Dilation of congenital valvular aortic stenosis using Inoue balloon. Cathet Cardiovasc Diagn 1997, 42:328-330.
71. Rao S, Jureidini S: Transumbilical venous, anterograde, snare-assisted balloon aortic valvuloplasty in a neonate with critical aortic stenosis. Cathet Cardiovasc Diagn 1998, 45:144-148.
72. Weber H, Mart C, Kupferschmid J, Myers J, Cyran S: Transcarotid balloon valvuloplasty with continuous transesophageal echocardiographic guidance for neonatal critical aortic valve stenosis: an alternative to surgical palliation. Pediatr Cardiol 1998, 19:212-217.
73. Gildein H, Kleinert S, Goh T, Wilkinson J: Pulmonary valve annulus grows after balloon dilatation of neonatal critical pulmonary valve stenosis. Am Heart J 1998, 136:276-280.
74. Kothari S, Kamath P, Juneja R, Bahl V, Airan B: Percutaneous transvenous mitral commisurotomy using Inoue balloon in children less than 12 years. Cathet Cardiovasc Diagn 1998, 43:408-411.
75. Zhang H, Ruiz C, Allen J, Lau F: A novel prognostic scoring system to predict late outcome after percutaneous balloon valvotomy in patients with severe mitral stenosis. Am Heart J 1997, 134:772-778.
76. Justo R, Nykanen D, Williams W, Freedom R, Benson L: Transcatheter perforation of the right ventricular outflow tract as initial therapy for pulmonary valve atresia and intact ventricular septum in the newborn. Cathet Cardiovasc Diagn 1997, 40:408-413.
77. Kuhn M, Mulla N, Dyar D, Cephus C, Larsen R: Valve perforation and balloon valvuloplasty in an infant with tetralogy of Fallot and pulmonary atresia. Cathet Cardiovasc Diagn 1997, 40:403-406.
78. Siblini G, Rao P, Singh G, Tinker K, Balfour I: Transcatheter management of neonatas with pulmonary atresia and intact ventricular septum. Cathet Cardiovasc Diagn 1997, 42:395-402.
79. Park I-S, Nakanishi T, Nakazawa M, Takanashi Y, Imai Y, Momma K: Radiofrequency pulmonary valvotomy using a new 2-French catheter. Cathet Cardiovasc Diagn 1998, 45:37-42.
80. Hijazi Z, Patel H, Cao Q-L, Warner K: Transcatheter retrograde radiofrequency perforation of the pulmonic valve in pulmonary atresia with intact ventricular septum, using a 2 French catheter. Cathet Cardiovasc Diagn 1998, 45:151-154.
81. Cheatham J, Coe J, Kugler J, Fletcher S, Tower A: Successful transcatheter perforation of the atretic pulmonary valve membrane in a newborn using the new Coe radiofrequency end hole catheter. Cathet Cardiovasc Diagn 1998, 45:162-166.
82. Yetman A, Nykanen D, McCrindle B, Sunnegardh J, Adatia I, Freedom R, Benson L: Balloon angioplasty of recurrent coarctation of the aorta. J Am Coll Cardiol 1997, 30:811-816.
83. Park Y, Lucas V, Slansky M, Kashani I, Rothman A: Balloon angioplasty of native aortic coarctation in infants 3 months of age and younger. Am Heart J 1997, 134:917-923.
84. Schamberger M, Lababidi Z: Successful balloon angioplasty of a coarctation in an infant < 500 g. Pediatr Cardiol 1998, 19:418-419.
85. Ohkubo M, Ino T, Nishimoto K, Takahashi K, Akimoto K, Yamashiro Y, Kawasaki S: Combined angioplasty and valvuloplasty for coexisting coarctation of the aorta and aortic stenosis in an infant. Cathet Cardiovasc Diagn 1998, 45:51-53.
86. Sreeram N, Hutter P, Silove P: Sustained high pressure double balloon angioplasty of calcified conduits. Heart 1999, 81:162-165.
87. desJardins S, Crowley D, Beekman R, Lloyd T: Utility of cardiac catheterization in pediatric cardiac patients on ECMO. Cathet Cardiovasc Intervent 1999, 46:62-67.
88. Seib P, Faulkner S, Erickson C, Van Devanter S, Harrell J, Fasules J, et al.: Blade and balloon atrial septostomy for left heart decompression in patients with severe ventricular dysfunction on extracorporeal membrane oxygenation. Cathet Cardiovasc Intervent 1999, 46:179-186.
89. Johnston T, Jaggers J, McGovern J, O'Laughlin M: Bedside transseptal balloon dilation atrial septostomy for decompression of the left heart during extracorporeal membrane oxygenation. Cathet Cardiovasc Intervent 1999, 46:197-199.
90. Miga D, Clark J, Cowart K, Radtke A: Transcatheter fenestration of hemi-Fontan baffles after completion of Fontan physiology using balloon dilation and stent placement. Cathet Cardiovasc Diagn 1998, 43:429-432.
91. Lemes V, Murphy A, Osterman F, Laschinger J, Kan J: Fenestration of extracardiac Fontan and reversal of protein-losing enteropathy: case report. Pediatr Cardiol 1998, 19:355-357.
92. Cheatham J, McCowan T, Fletcher S: Percutaneous translumbar cardiac catheterization and central venous tine insertion: an alternative approach in children with congenital heart disease. Cathet Cardiovasc Intervent 1999, 46:187-192.
93. Robards J, Jaques P, Bauro M, Azizkhan R: Percutaneous translumbar inferior vena cava central line placement in a critically ill child. Pediatr Radiol 1999, 19:140-141.
94. Book W, Raviele A, Vincent R: Repetitive percutaneous transhepatic access for myocardial biopsy in pediatric cardiac transplant recipients. Cathet Cardiovasc Diagn 1998, 45:167-169.
95. Erenberg F, Shim D, Beekman R: Intraperitoneal hemorrhage associated with transhepatic cardiac catheterization: a report of two cases. Cathet Cardiovasc Diagn 1998, 43:177-178.
96. Vitiello, R, McCrindle B, Nykanen D, Freedom R, Benson L: Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 1998, 32:1433-1440. Complications of pediatric cardiac catheterization were studied in a review of 4952 consecutive procedures performed over a 7-year period. One or more complications were reported in 436 studies (8.8%). Seven deaths (0.14%) occurred as a direct complication of the procedure and 189 vascular complications (3.8%) constituted the most common adverse events.